Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Where is Merck & Co., Inc. (MRK) Headed According to the Street?
Burling Wealth Partners LLC Sells 9,333 Shares of Merck & Co., Inc. $MRK
First National Bank of Omaha Makes New Investment in Merck & Co., Inc. $MRK
Second season results from the Phase 3 SMART trial were pres
Merck (MRK) Valuation Check As Keytruda SC Approval And Mayo Clinic AI Deal Shape Growth Story
Short Interest in Merck & Co., Inc. (NYSE:MRK) Decreases By 14.6%
Merck & Company Stock Forecast 2026-2030 | Future Outlook | Capital.com
Health Canada Approves KEYTRUDA SC™, a subcutaneous formulation of pembrolizumab across multiple cancer indications
Mondrian Investment Partners LTD Takes Position in Merck & Co., Inc. $MRK - Markets Daily
Merck & Co., Inc. $MRK Shares Purchased by NEOS Investment Management LLC
GSA Capital Partners LLP Raises Stock Holdings in Merck & Co., Inc. $MRK - Markets Daily
Merck & Co., Inc. $MRK Stake Lessened by Skandinaviska Enskilda Banken AB publ
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Bancorp
Mondrian Investment Partners LTD Invests $138.34 Million in Merck & Co., Inc. $MRK - Stock Observer
M&G PLC Has $30.49 Million Stock Position in Merck & Co., Inc. $MRK
Vanguard Group Inc. Sells 777,516 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Sold by Tobam | MarketBeat
Pallas Capital Advisors LLC Grows Stake in Merck & Co., Inc. $MRK - Markets Daily
Texas Yale Capital Corp. Has $4.83 Million Stake in Merck & Co., Inc. $MRK - Daily Political
Merck & Co., Inc. $MRK Shares Sold by Shell Asset Management Co.
Merck & Co., Inc. $MRK Shares Acquired by Calton & Associates Inc.
Hardy Reed LLC Sells 8,831 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Bought by HighTower Advisors LLC
Merck & Co., Inc. $MRK Shares Sold by ABN Amro Investment Solutions
Aberdeen Group plc Sells 46,708 Shares of Merck & Co., Inc. $MRK
A Look At Merck (MRK) Valuation After New Keytruda Approval And Oncology Data Updates
Deutsche Bank Aktiengesellschaft Upgrades Merck & Co., Inc. (NYSE:MRK) to "Buy" - Daily Political
HighTower Advisors LLC Boosts Stake in Merck & Co., Inc. $MRK - Daily Political
Merck & Co., Inc. $MRK Shares Sold by Public Sector Pension Investment Board
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year High Following Analyst Upgrade
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA® and KEYTRUDA QLEX™ Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc.
Have Merck Insiders Been Selling Stock?
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co
Krilogy Financial LLC Buys 21,122 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. (NYSE:MRK) CMO Sells $1,184,100.00 in Stock - Markets Daily
Caprock Group LLC Invests $5.33 Million in Merck & Co., Inc. $MRK
Dentsu Creative Vietnam positions HPV prevention as a modern Tết ritual for MSD
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
Rhumbline Advisers Sells 8,850 Shares of Merck & Co., Inc. $MRK
Stratos Wealth Partners LTD. Acquires 26,639 Shares of Merck & Co., Inc. $MRK
KEYTRUDA and KEYTRUDA QLEX are the first and only PD-1 inhib
Wealthfront Advisers LLC Raises Stock Holdings in Merck & Co., Inc. $MRK
Edgemoor Investment Advisors Inc. Cuts Stake in Merck & Co., Inc. $MRK
Advisors Asset Management Inc. Grows Holdings in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stock Position Boosted by ING Groep NV - Stock Observer
Julien Nono-Womdim's Top Picks: Citigroup, Merck & Celestica - BNN Bloomberg
First National Trust Co Has $16.91 Million Stock Holdings in Merck & Co., Inc. $MRK - Markets Daily
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc.
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK
Midwest Trust Co Purchases 24,910 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC
Costello Asset Management INC Decreases Stake in Merck & Co., Inc. $MRK
Oppenheimer & Co. Inc. Decreases Position in Merck & Co., Inc. $MRK - Daily Political
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock
Chirfi Guindo Sells 10,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock
OPTIMAS CAPITAL Ltd Makes New Investment in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A.
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK
New York Life Investment Management LLC Decreases Holdings in Merck & Co., Inc. $MRK - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Downgraded by Wall Street Zen to Buy - Daily Political
Merck & Co. Inc. (MRK) - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Cut to "Buy" at Wall Street Zen
Assessing Merck (MRK) Valuation After Enflonsia Approval And Steady Keytruda Momentum
Merck & Co., Inc. (MRK): A Bull Case Theory
Wellington Shields & Co. LLC Has $2.04 Million Stock Holdings in Merck & Co., Inc. $MRK - Markets Daily
Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC
Garland Capital Management Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - Stock Observer
Wescott Financial Advisory Group LLC Sells 6,831 Shares of Merck & Co., Inc. $MRK - Stock Observer
Murphy Pohlad Asset Management LLC Has $1.43 Million Holdings in Merck & Co., Inc. $MRK - Daily Political
Jim Cramer Says Stocks Like Johnson & Johnson "Simply Refuse to Quit"
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares
Merck & Co., Inc. (NYSE:MRK) SVP Sells $765,888.00 in Stock
Chirfi Guindo Sells 20,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock
Merck & Co., Inc. (NYSE:MRK) VP Dean Li Sells 15,087 Shares
Merck & Co., Inc. (NYSE:MRK) CEO Sells $5,599,109.36 in Stock
Merck & Co., Inc. (NYSE:MRK) CFO Caroline Litchfield Sells 41,997 Shares
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.8% Following Analyst Upgrade
Merck & Co., Inc. (NYSE:MRK) Trading 1.8% Higher Following Analyst Upgrade - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $140.00
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells 37,685 Shares of Stock - Daily Political
Johannes Jacobus Oosthuizen Sells 15,000 Shares of Merck & Co., Inc. (NYSE:MRK) Stock - Daily Political
Willis Investment Counsel Raises Stake in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Holdings Cut by Fishman Jay A Ltd. MI
Bessemer Group Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK
Guggenheim Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - Daily Political
John G Ullman & Associates Inc. Raises Stock Holdings in Merck & Co., Inc. $MRK - Stock Observer
MerckCo News
Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?
Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?
Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?
Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?
